Cytosorbents CorporationCTSONASDAQ
Loading
P/E Ratio: Premium ValuationElevated
Percentile Rank86
Studio
Year-over-Year Change

Price-to-earnings ratio

Latest
-2.39
↑ 81% vs avg
Percentile
P86
Within normal range
Streak
1 yr
Consecutive declineElevated
Average
-12.38
Historical baseline
PeriodValueYoY Change
2024-2.39-41.1%
2023-1.69+17.7%
2022-2.06+72.2%
2021-7.40+81.3%
2020-39.48-512.5%
2019-6.45+55.3%
2018-14.42+32.0%
2017-21.21-82.7%
2016-11.61+31.9%
2015-17.05-